Minimizing infliximab toxicity in the treatment of inflammatory bowel disease
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference81 articles.
1. Serious infections and mortality in association with tharapies for Crohn's disease: TREAT Registry;Lichtenstein;Clin Gastroen-terol Hepatol,2006
2. Data on file-Centocor, accessed Aug-Oct, 2006.
3. Immunogenicity of engineered antibodies;Hwang;Methods,2005
4. Maintenance Infliximab for Crohn's disease: the ACCENT I randomised trial;Hanauer;Lancet,2002
5. The safety profile of Infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients;Colombel;Gastroenterology,2004
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Natural Products as Dietary Agents for the Prevention and Mitigation of Oxidative Damage and Inflammation in the Intestinal Barrier;Antioxidants;2024-01-01
2. Reversing Ongoing Chronic Intestinal Inflammation and Fibrosis by Sustained Block of IL-12 and IL-23 Using a Vaccine in Mice;Inflammatory Bowel Diseases;2018-05-17
3. Cytokine expression and the role of Th17 cells in a mouse model of colitis;Molecular Medicine Reports;2012-09-28
4. Anti–Tumor Necrosis Factor–α Monoclonal Antibody Alleviates Parenteral Nutrition–Associated Liver Disease in Mice;Journal of Parenteral and Enteral Nutrition;2012-01-24
5. Guidelines for the Management of Ulcerative Colitis;Intestinal Research;2012
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3